MSD India launches 9-valent Human Papillomavirus (HPV) vaccine, GARDASIL 9
India’s first gender-neutral HPV vaccine to help reduce HPV -related disease burden in Indian girls, women and boys
India’s first gender-neutral HPV vaccine to help reduce HPV -related disease burden in Indian girls, women and boys
In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report
The company plans to launch its exclusive e-pharmacy and telemedicine services in India by December 2021
UFlex has committed close to US $ 10 million towards various initiatives at its overseas and Indian plants to repurpose plastic waste
Terumo’s first product was the domestically produced, safe, high-quality thermometer. The company has since supported the healthcare ecosystem worldwide
In India, almost all approved vaccines are packed in FIOLAX glass made by SCHOTT
The bank will provide a complete range of financing options including hospitals, labs, diagnostic centres and equipment manufacturers
The investment will be used to develop affordable Point of Care labs with 70+ tests. Mylab will start deploying systems with its lab partners from Nov 2021
The investment will be used to develop affordable Point of Care labs with 70+ tests. Mylab will start deploying systems with its lab partners from Nov 2021
The clinical trial, to be conducted in two phases, will evaluate the safety and efficacy of Mesocel for the treatment of patients with moderate to severe Covid-19
Subscribe To Our Newsletter & Stay Updated